Citation Impact
Citing Papers
Cancer Immunotherapy Targeting the High Molecular Weight Melanoma-Associated Antigen Protein Results in a Broad Antitumor Response and Reduction of Pericytes in the Tumor Vasculature
2008
Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense
2016 Standout
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Sexually transmitted diseases treatment guidelines (2015)
2015 Standout
Epithelialization in Wound Healing: A Comprehensive Review
2014 Standout
Infections Due to Rapidly Growing Mycobacteria
2006
Interventions to improve antibiotic prescribing practices for hospital inpatients
2017 Standout
IFN-β Increases Listeriolysin O-Induced Membrane Permeabilization and Death of Macrophages
2008
Sero-Diagnosis of Mycobacterium avium Complex Lung Disease Using Serum Immunoglobulin A Antibody against Glycopeptidolipid Antigen in Taiwan
2013
Group A Streptococcus Activates Type I Interferon Production and MyD88-dependent Signaling without Involvement of TLR2, TLR4, and TLR9
2008 StandoutNobel
Lack of Adherence to Evidence-based Treatment Guidelines for Nontuberculous Mycobacterial Lung Disease
2014
Efficacy of Clarithromycin and Ethambutol for Mycobacterium avium Complex Pulmonary Disease. A Preliminary Study
2014
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Early Pulmonary Resection for Mycobacterium Avium Complex Lung Disease Treated With Macrolides and Quinolones
2006
Association of SLC11A1 (NRAMP1) polymorphisms with pulmonary Mycobacterium avium complex infection
2012
Relationship between clinical efficacy of treatment of pulmonary Mycobacterium avium complex disease and drug-sensitivity testing of Mycobacterium avium complex isolates
2006
The MACPF/CDC family of pore-forming toxins
2008
Methicillin-resistant Staphylococcus aureus bacteremia at a university hospital in Japan
2012
Nutritional immunity: transition metals at the pathogen–host interface
2012 Standout
Azithromycin-Containing Regimens for Treatment of Mycobacterium avium Complex Lung Disease
2001
Natural products: An evolving role in future drug discovery
2011 Standout
Infectious Diseases Consultation Lowers Mortality From Staphylococcus aureus Bacteremia
2009
A double-blind randomized study of aminoglycoside infusion with combined therapy for pulmonary Mycobacterium avium complex disease
2006
Pulmonary Disease Due to Nontuberculous Mycobacteria
2008
Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy
2008
Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria
2012
Long-term Follow-up of Mycobacterium avium Complex Lung Disease in Patients Treated With Regimens Including Clofazimine and/or Rifampin
2015
Epigallocatechin gallate inhibits intracellular survival of Listeria monocytogenes in macrophages
2007
The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease
2008
First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol
2001
Prevalence and hazardous impact of pharmaceutical and personal care products and antibiotics in environment: A review on emerging contaminants
2021 Standout
Macrolide/Azalide Therapy for Nodular/Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
Relationship between clinical efficacy for pulmonary MAC and drug-sensitivity test for isolated MAC in a recent 6-year period
2011
Type I interferons in infectious disease
2015 Standout
Treatment of Mycobacterium avium-intracellulare complex Lung Disease With a Macrolide, Ethambutol, and Clofazimine
2003
Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy
2013 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
HIF-1 and mechanisms of hypoxia sensing
2001 StandoutNobel
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
THP-1 cell line: An in vitro cell model for immune modulation approach
2014 Standout
Serial CT Findings ofMycobacterium massiliensePulmonary Disease Compared withMycobacterium abscessusDisease after Treatment with Antibiotic Therapy
2012
Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia
2010
Nontuberculous mycobacterial (NTM) lung disease: The top ten essentials
2013
Heme Oxygenase-1/Carbon Monoxide: From Basic Science to Therapeutic Applications
2006 Standout
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease
2011
PulmonaryMycobacterium aviumcomplex infection: association withNRAMP1polymorphisms
2007
Bronchiectasis and Nontuberculous Mycobacterial Disease
2012
Lady Windermere revisited: treatment with thoracoscopic lobectomy/segmentectomy for right middle lobe and lingular bronchiectasis associated with non-tuberculous mycobacterial disease☆
2011
Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis
2010 Standout
Mycobacterium aviumcomplex disease: prognostic implication of high-resolution computed tomography findings
2008
Interventions to improve antibiotic prescribing practices for hospital inpatients
2013 Standout
IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction
2005 Standout
Increased blood carboxyhaemoglobin concentrations in inflammatory pulmonary diseases
2002
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
2015
Surgery for Mycobacterium avium complex lung disease in the clarithromycin era
2002
US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis: executive summary
2015
The clinical impact of glycobiology: targeting selectins, Siglecs and mammalian glycans
2021 StandoutNobel
Rapid identification and antimicrobial susceptibility testing reduce antibiotic use and accelerate pathogen-directed antibiotic use
2007
The Microbiological and Clinical Effects of Combined Therapy according to Guidelines on the Treatment of Pulmonary <i>Mycobacterium avium </i>Complex Disease in Japan – Including a Follow-Up Study
2006
Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores
2016 StandoutNature
Amino acids and immune function
2007 Standout
Streptolysin O enhances keratinocyte migration and proliferation and promotes skin organ culture wound healing in vitro
2007
Therapeutic Effects of Various Initial Combinations of Chemotherapy Including Clarithromycin Against Mycobacterium avium Complex Pulmonary Disease
2009
Natural Killer (NK) Cells in Antibacterial Innate Immunity: Angels or Devils?
2011
Mycobacterium avium complex Pulmonary Disease in Patients Without HIV Infection
2004
Antioxidant/Pro-oxidant Equilibrium Regulates HIF-1α and NF-κB Redox Sensitivity
2000
Recent advances in understanding the antibacterial properties of flavonoids
2011 Standout
Occurrence of antibiotics and antibiotic resistance genes in hospital and urban wastewaters and their impact on the receiving river
2014
Familial Clustering of Pulmonary Nontuberculous Mycobacterial Disease
2009
Impact of infectious diseases service consultation on diagnosis of infective endocarditis
2011
Update on the Management of Gonorrhea in Adults in the United States
2007
Signaling to NF-κB by Toll-like receptors
2007 Standout
Clinical and Molecular Analysis of Macrolide Resistance in Mycobacterium avium Complex Lung Disease
2006
An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases
2007 Standout
Prognostic Factors of 634 HIV-Negative Patients with Mycobacterium avium Complex Lung Disease
2011
Ethambutol Ocular Toxicity in Treatment Regimens for Mycobacterium avium Complex Lung Disease
2005
Factors Related to Response to Intermittent Treatment of Mycobacterium avium Complex Lung Disease
2006
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
Abnormal Nasal Nitric Oxide Production, Ciliary Beat Frequency, and Toll-like Receptor Response in Pulmonary Nontuberculous Mycobacterial Disease Epithelium
2013
Intermittent Antibiotic Therapy for Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease
2014
A Laboratory-based Analysis of Nontuberculous Mycobacterial Lung Disease in Japan from 2012 to 2013
2016 Standout
Nontuberculous Mycobacteria
2003
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Practice Guidelines for the Diagnosis and Management of Skin and Soft Tissue Infections: 2014 Update by the Infectious Diseases Society of America
2014 Standout
Emergence of Multidrug-Resistant, Extensively Drug-Resistant and Untreatable Gonorrhea
2012
Drug Susceptibility Testing of Nontuberculous Mycobacteria
2014
Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses
2009 Standout
Siglec-7 engagement by GBS β-protein suppresses pyroptotic cell death of natural killer cells
2018
Production of superoxide and TNF-α from alveolar macrophages is blunted by glycine
1999
Bacterial Biofilm and its Role in the Pathogenesis of Disease
2020 Standout
Faropenem Medoxomil
2007
Hot Tub Associated Granulomatous Lung Disease From Mycobacterial Bioaerosols
2008
Production of Type I IFN Sensitizes Macrophages to Cell Death Induced by Listeria monocytogenes
2002
Ethambutol Pharmacokinetic Variability Is Linked to Body Mass in Overweight, Obese, and Extremely Obese People
2011
IFN Regulatory Factor 3-Dependent Induction of Type I IFNs by Intracellular Bacteria Is Mediated by a TLR- and Nod2-Independent Mechanism
2004
Sexually Transmitted Diseases Treatment Guidelines, 2010
2011 Standout
Diagnosis and Treatment of Nontuberculous Mycobacterial Lung Disease
2016
Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future
2014 Standout
Optimizing ethambutol dosing among HIV/tuberculosis co-infected patients: a population pharmacokinetic modelling and simulation study
2019 StandoutNobel
The role of pneumolysin in pneumococcal pneumonia and meningitis
2004
The Inflammasomes: Guardians of the Body
2009 Standout
Infection Source and Epidemiology of Nontuberculous Mycobacterial Lung Disease
2018 Standout
Standardized Combination Antibiotic Treatment ofMycobacterium aviumComplex Lung Disease
2010
Dynamin inhibition interferes with inflammasome activation and cytokine gene expression inStreptococcus pyogenes-infected human macrophages
2014 StandoutNobel
HIF-1 and human disease: one highly involved factor
2000 StandoutNobel
Insertion Sequence 1515 in the ply Gene of a Type 1 Clinical Isolate of Streptococcus pneumoniae Abolishes Pneumolysin Expression
2007 StandoutNobel
Dependency of Caspase-1 Activation Induced in Macrophages by Listeria monocytogenes on Cytolysin, Listeriolysin O, after Evasion from Phagosome into the Cytoplasm
2008
The Effect of Combined Therapy According to the Guidelines for the Treatment of Mycobacterium avium Complex Pulmonary Disease
2003
Pneumolysin-Dependent and -Independent Gene Expression Identified by cDNA Microarray Analysis of THP-1 Human Mononuclear Cells Stimulated byStreptococcus pneumoniae
2003
Works of T Kimoto being referenced
Polypoid bronchial lesions due to Scedosporium apiospermum in a patient with Mycobacterium avium complex pulmonary disease
1998
Improved Clinical Outcome of Patients With Candida Bloodstream Infections Through Direct Consultation by Infectious Diseases Physicians in a Japanese University Hospital
2006
Successful treatment with faropenem and clarithromycin of pulmonary Mycobacterium abscessus infection
2002
Effect of Clarithromycin Regimen for Mycobacterium avium Complex Pulmonary Disease
1999
Familial Pulmonary Mycobacterium avium Complex Disease
2000
Essential Role of Interleukin-12 (IL-12) and IL-18 for Gamma Interferon Production Induced by Listeriolysin O in Mouse Spleen Cells
2002
Differences in Gamma Interferon Production Induced by Listeriolysin O and Ivanolysin O Result in Different Levels of Protective Immunity in Mice Infected with Listeria monocytogenes and Listeria ivanovii
2003
Irreversible loss of membrane-binding activity of Listeria-derived cytolysins in non-acidic conditions: a distinct difference from allied cytolysins produced by other Gram-positive bacteria
2007
Seeligeriolysin O, a Cholesterol-Dependent Cytolysin ofListeria seeligeri, Induces Gamma Interferon from Spleen Cells of Mice
2002
Induction of Gamma Interferon and Nitric Oxide by Truncated Pneumolysin That Lacks Pore-Forming Activity
2002
Dissociated Linkage of Cytokine-Inducing Activity and Cytotoxicity to Different Domains of Listeriolysin O from Listeria monocytogenes
2002